BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36044873)

  • 21. Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.
    Cham S; Chen L; St Clair CM; Hou JY; Tergas AI; Melamed A; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2019 Jun; 220(6):571.e1-571.e8. PubMed ID: 30771346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Institutional Case Volume on In-hospital Mortality After Living Donor Liver Transplantation: Analysis of 7073 Cases Between 2007 and 2016 in Korea.
    Yoo S; Jang EJ; Yi NJ; Kim GH; Kim DH; Lee H; Jung CW; Ryu HG
    Transplantation; 2019 May; 103(5):952-958. PubMed ID: 30086090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of contemporary trends in access to high-volume ovarian cancer surgical care.
    Bristow RE; Puri I; Diaz-Montes TP; Giuntoli RL; Armstrong DK
    Ann Surg Oncol; 2009 Dec; 16(12):3422-30. PubMed ID: 19711131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cancer surgery in Maryland: volume-based access to care.
    Bristow RE; Zahurak ML; del Carmen MG; Gordon TA; Fox HE; Trimble EL; Montz FJ
    Gynecol Oncol; 2004 May; 93(2):353-60. PubMed ID: 15099945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can regionalization decrease the number of deaths for children who undergo cardiac surgery? A theoretical analysis.
    Chang RK; Klitzner TS
    Pediatrics; 2002 Feb; 109(2):173-81. PubMed ID: 11826192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
    Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
    Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
    J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer.
    Wright JD; Huang Y; Melamed A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jun; 133(6):1109-1119. PubMed ID: 31135724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult lung transplantation case-volume and in-hospital and long-term mortality in Korea.
    Yoon S; Jang EJ; Kim GH; Kim DH; Lim TY; Lee H; Ryu HG
    J Cardiothorac Surg; 2019 Jan; 14(1):19. PubMed ID: 30674327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
    Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
    Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York State.
    Kahn RM; Ma X; Gordhandas S; Yeoshoua E; Ellis RJ; Zhang X; Aviki EM; Abu-Rustum NR; Gardner GJ; Sonoda Y; Zivanovic O; Long Roche K; Jewell E; Boerner T; Chi DS
    Gynecol Oncol; 2024 Mar; 182():141-147. PubMed ID: 38262237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data.
    Amato L; Fusco D; Acampora A; Bontempi K; Rosa AC; Colais P; Cruciani F; D'Ovidio M; Mataloni F; Minozzi S; Mitrova Z; Pinnarelli L; Saulle R; Soldati S; Sorge C; Vecchi S; Ventura M; Davoli M
    Epidemiol Prev; 2017; 41(5-6 (Suppl 2)):1-128. PubMed ID: 29205995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival outcomes for robotic-assisted laparoscopy versus traditional laparoscopy in clinical stage I epithelial ovarian cancer.
    Facer B; Wang F; Grijalva CG; Alvarez RD; Shu XO
    Am J Obstet Gynecol; 2020 May; 222(5):474.e1-474.e12. PubMed ID: 31715149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: a propensity-matched analysis.
    Xu M; Zhang W; Gao C; Zhou Y; Xie Y
    BMC Anesthesiol; 2022 Apr; 22(1):120. PubMed ID: 35461230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Volume on Mortality and Hospital Stay After Lung Cancer Surgery in a Single-Payer System.
    Pollock C; Soder S; Ezer N; Ferraro P; Lafontaine E; Martin J; Nasir B; Liberman M
    Ann Thorac Surg; 2022 Nov; 114(5):1834-1841. PubMed ID: 34736929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers.
    Nguyen NT; Paya M; Stevens CM; Mavandadi S; Zainabadi K; Wilson SE
    Ann Surg; 2004 Oct; 240(4):586-93; discussion 593-4. PubMed ID: 15383786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.